SlideShare a Scribd company logo
CLINICAL CHEMISTRY 1
LECTURE 1: Introduction to Clinical
chemistry and the clinical chemistry
laboratory
P.B.B. Moyo, Msc(BMS)
Department of Biomedical Science
Malamulo College of Health Sciences
Makwasa, March 23rd , 2015
3BMSCC1lec1IntroductionPmoyo18th
March2015
1
COURSE OVERVIEW
• AIM: This course aims at providing students with
knowledge, attitude and skills required to perform
clinical chemistry investigations correctly,
supervise technicians and provide sound advice to
clinicians about the same wherever necessary.
• GENERAL OBJECTIVES: By the end of this course
you should be able to:
1. Describe the scope of clinical chemistry
2. Apply the principles of measurement indicated
for CCL
3. Describe structure and metabolism of CHON,
CHO, Lipids, Hormones, Electrolytes,
Elements, and Organic bio-compounds
3BMSCC1lec1IntroductionPmoyo18th
March2015
2
Course overview continued
4. Describe specimen requirement specifications on
patient preparation, specimen collection and handling
appropriately
5. Perform investigations and analyses of the
parameters in 3, above
6. Apply quality assurance principles and measures in
the CCL
7. Provide information, education and communication
(IEC) to the public regarding CCL roles
8.Provide required supervision for biomedical
tecnnicians
9. Provide technical support to management and other
hospital sub-systems.
3BMSCC1lec1IntroductionPmoyo18th
March2015
3
Lesson Overview
• Define related terms
• List the factors that led to the development of
clinical chemistry
• State the rationale of laboratory medicine and
clinical chemistry in particular
• Point out the areas of interests or benefits of
clinical chemistry
3BMSCC1lec1IntroductionPmoyo18th
March2015
4
The scope of clinical chemistry
• Introduction
1) what it is
2) why study it
3) How it is studied
4) Requirements:
- equipment
- personnel
- reagents and test kits
- consumable supplies
3BMSCC1lec1IntroductionPmoyo18th
March2015
5
Areas of interest-1
3BMSCC1lec1IntroductionPmoyo18th
March2015
6
Biochemistry
Endocrinology
Analytical
chemistry
Immunology
Instrumentation
Pharmacology
Toxicology
other
Computers
Clinical
Chemistry
employs
history
• Synthesis of urea by Friedrich Wohler in 1800
- exploration of life phenomenon to replace the
misconception that ‘life was but a series of chemical
reactions’
- Crude techniques but advances to understand the living
material were made despite limitations, in the 19th
century. Viz;
1) discovery of starch, fats and some blood proteins were
isolated and characterised
2) Cholesterol in gall stones
3) chemical composition of urine
• 1815 urine test for diabetes and CHO metabolism
investigations started
• 1836 The first clinical chemistry book was published
3BMSCC1lec1IntroductionPmoyo18th
March2015
7
history
• Further developments in the 1900s
- Ph meter-initially for citrus acidity testing but
adapted to ph in assays, its effect on RR and
later test blood pH to identify and
monitor ABB treatment
- Colorimeters-electronic measurement replaced
visual comparison reacted tests with
standard solutions i.e. objectivity replaced
subjectivityESULTED IN INCREASED ACCURACY
AND PRODUCTIVITY
Provided the basis for the discovery of automated
analysers in use today
3BMSCC1lec1IntroductionPmoyo18th
March2015
8
History – Advanced testing
• 2. Dr. L. Skeggs discovered the Technicon
Autoanalyser
• 3. 1970 Radioisotopes were used in assays
Scintillation counting devices
Immunoassays
• 4. Incorporation or linkage of computers to
laboratory equipment
- ability for data processing
- monitoring of data produced
- ensured accuracy
- correlations and relationships with previous
information (eg. Delta checks)
3BMSCC1lec1IntroductionPmoyo18th
March2015
9
Explosion of biochemical knowledge
• 1. Deep probing into mysteries resulted from
increased knowledge and use of instrumentation
• More details could be revealed using a very small
sample and in a very short time (test turn around
time was greatly reduced)
• 2. Hormone studies, enzyme activities, and
electrophoresis, plus pharmacological
investigations on drug levels became the order of
the day
• Therefore, clinical chemistry has become and
indispensable necessity in modern, evidence
based medicine
3BMSCC1lec1IntroductionPmoyo18th
March2015
10
Current Interests
• 1. Indicators of a healthy life style – regular
check ups e.g. Cholesterol, blood sugar
• 2. Predictors of heart disease eg. Lipoproteins
• 3. Markers of mental ilnes or cancer eg. Cortisol
or Alfa Feto Protein (AFP)
• 4. Disease specific protein markers eg. C-reactive
protein and Ceruloplasmin
• 5. Nutritional assessment- the healing process
and mineral status
• 6. Treatment monitoring eg. LFTs in ARV therapy
• 7. General maintenance of health
3BMSCC1lec1IntroductionPmoyo18th
March2015
11
The Future of Clinical chemistry
• 1. Certainty-more areas to explore: genetic studies, DNA
probes consequently, may permit rapid and accurate
detection of metabolic disorders and inborn errors of
metabolism
• 2. Forensic chemistry- use of DNA in partenity testing,
identification of criminals and drug screaning for
substance abuse eg. Athlets
• 3. Development potential evidenced by:
-Ion Selective Electrodes-pHM? Mbfconst.acc
- Bedside (lab)testing
-Paediatric patients versus adult values
4. Contributions through research discovery and
ellaboration of new and existing functions and roles of
certain molecules
• Politics and economics will drive the future of clinical
chemistry 3BMSCC1lec1IntroductionPmoyo18th
March2015
12
The clinical chemistry laboratory
1. Personnel
2. SOPs
3. Specimens-patient preparation,
collection, transport and storage
4. Methods - choice criteria
5. Equipment – choice and proper use
•Results and Records
6. Quality assurance
3BMSCC1lec1IntroductionPmoyo18th
March2015
13
Prerequisites of clinical chemistry work
• The scientific notation of use of (systeme
internationale )SI units
• Ability to make bake basic computations
applicable to the clinical chemistry laboratory
• Availability and use of quality water: one that
meets specific requirements
• Availability and use of quality chemicals,
reagents and consumable supplies
• Adherence to collection, transport, handling and
processing or testing of specimens
• Application of safety and quality assurance
measure in clinical chemistry laboratory work
3BMSCC1lec1IntroductionPmoyo18th
March2015
14
Summary
1. Clinical chemistry scope covers several branches
2. CC developed rapidly with the synthesis of urea
due to its relation to life
3. Instrumentation made laboratory testing more
efficient and productive with reduced turn around
time
4. CC provides the bases for diagnostic, prognostic,
forensic and drug monitoring
5. CC has pointed out special areas of interest in
human health and indicators of impending
diseases
6. Despite the important roles, CC success is
dependent on government policies and the
economy of a country
3BMSCC1lec1IntroductionPmoyo18th
March2015
15

More Related Content

Similar to introductiontoclinicalchemistry-150421021353-conversion-gate01.pdf

32_Clinical Laboratory Visit - III.pdf
32_Clinical Laboratory Visit -  III.pdf32_Clinical Laboratory Visit -  III.pdf
32_Clinical Laboratory Visit - III.pdf
Vamsi kumar
 
52_Clinical Laboratory Visit - VI.pdf
52_Clinical Laboratory Visit - VI.pdf52_Clinical Laboratory Visit - VI.pdf
52_Clinical Laboratory Visit - VI.pdf
Vamsi kumar
 
38_Clinical Laboratory Visit - IV.pdf
38_Clinical Laboratory Visit - IV.pdf38_Clinical Laboratory Visit - IV.pdf
38_Clinical Laboratory Visit - IV.pdf
Vamsi kumar
 
Bioanlytical method development
Bioanlytical method developmentBioanlytical method development
Bioanlytical method development
Sagar Savale
 
9_Laboratory Management.pdf
9_Laboratory Management.pdf9_Laboratory Management.pdf
9_Laboratory Management.pdf
Vamsi kumar
 
20_Basics of Haematological diseases.pdf
20_Basics of Haematological diseases.pdf20_Basics of Haematological diseases.pdf
20_Basics of Haematological diseases.pdf
Vamsi kumar
 
43_Program Elective course - III (Community medicine).pdf
43_Program Elective course - III (Community medicine).pdf43_Program Elective course - III (Community medicine).pdf
43_Program Elective course - III (Community medicine).pdf
Vamsi kumar
 
27_Analytical Clinical Biochemistry.pdf
27_Analytical Clinical Biochemistry.pdf27_Analytical Clinical Biochemistry.pdf
27_Analytical Clinical Biochemistry.pdf
Vamsi kumar
 
53_MLT Internship.pdf
53_MLT Internship.pdf53_MLT Internship.pdf
53_MLT Internship.pdf
Vamsi kumar
 
A Review on Step-by-Step Analytical Method Validation
A Review on Step-by-Step Analytical Method ValidationA Review on Step-by-Step Analytical Method Validation
A Review on Step-by-Step Analytical Method Validation
iosrphr_editor
 
Urine analysis case study
Urine analysis case studyUrine analysis case study
Urine analysis case study
biniyapatel
 
Clinical trials phases 0 3
Clinical trials phases 0 3Clinical trials phases 0 3
Clinical trials phases 0 3
Seth GSMC and KEM Municipal Hospital
 
5_Medical Law and Ethics.pdf
5_Medical Law and Ethics.pdf5_Medical Law and Ethics.pdf
5_Medical Law and Ethics.pdf
Vamsi kumar
 
42_Cytopathology.pdf
42_Cytopathology.pdf42_Cytopathology.pdf
42_Cytopathology.pdf
Vamsi kumar
 
40_Advanced Haematology.pdf
40_Advanced Haematology.pdf40_Advanced Haematology.pdf
40_Advanced Haematology.pdf
Vamsi kumar
 
GLP-CONCEPT.ppt
GLP-CONCEPT.pptGLP-CONCEPT.ppt
GLP-CONCEPT.ppt
iamviksin
 
18_Clinical Laboratory Visit - I.pdf
18_Clinical Laboratory Visit - I.pdf18_Clinical Laboratory Visit - I.pdf
18_Clinical Laboratory Visit - I.pdf
Vamsi kumar
 
21_Biochemical metabolism.pdf
21_Biochemical metabolism.pdf21_Biochemical metabolism.pdf
21_Biochemical metabolism.pdf
Vamsi kumar
 
2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, LeidenAlain van Gool
 
Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...
Parul Institute of Pharmacy
 

Similar to introductiontoclinicalchemistry-150421021353-conversion-gate01.pdf (20)

32_Clinical Laboratory Visit - III.pdf
32_Clinical Laboratory Visit -  III.pdf32_Clinical Laboratory Visit -  III.pdf
32_Clinical Laboratory Visit - III.pdf
 
52_Clinical Laboratory Visit - VI.pdf
52_Clinical Laboratory Visit - VI.pdf52_Clinical Laboratory Visit - VI.pdf
52_Clinical Laboratory Visit - VI.pdf
 
38_Clinical Laboratory Visit - IV.pdf
38_Clinical Laboratory Visit - IV.pdf38_Clinical Laboratory Visit - IV.pdf
38_Clinical Laboratory Visit - IV.pdf
 
Bioanlytical method development
Bioanlytical method developmentBioanlytical method development
Bioanlytical method development
 
9_Laboratory Management.pdf
9_Laboratory Management.pdf9_Laboratory Management.pdf
9_Laboratory Management.pdf
 
20_Basics of Haematological diseases.pdf
20_Basics of Haematological diseases.pdf20_Basics of Haematological diseases.pdf
20_Basics of Haematological diseases.pdf
 
43_Program Elective course - III (Community medicine).pdf
43_Program Elective course - III (Community medicine).pdf43_Program Elective course - III (Community medicine).pdf
43_Program Elective course - III (Community medicine).pdf
 
27_Analytical Clinical Biochemistry.pdf
27_Analytical Clinical Biochemistry.pdf27_Analytical Clinical Biochemistry.pdf
27_Analytical Clinical Biochemistry.pdf
 
53_MLT Internship.pdf
53_MLT Internship.pdf53_MLT Internship.pdf
53_MLT Internship.pdf
 
A Review on Step-by-Step Analytical Method Validation
A Review on Step-by-Step Analytical Method ValidationA Review on Step-by-Step Analytical Method Validation
A Review on Step-by-Step Analytical Method Validation
 
Urine analysis case study
Urine analysis case studyUrine analysis case study
Urine analysis case study
 
Clinical trials phases 0 3
Clinical trials phases 0 3Clinical trials phases 0 3
Clinical trials phases 0 3
 
5_Medical Law and Ethics.pdf
5_Medical Law and Ethics.pdf5_Medical Law and Ethics.pdf
5_Medical Law and Ethics.pdf
 
42_Cytopathology.pdf
42_Cytopathology.pdf42_Cytopathology.pdf
42_Cytopathology.pdf
 
40_Advanced Haematology.pdf
40_Advanced Haematology.pdf40_Advanced Haematology.pdf
40_Advanced Haematology.pdf
 
GLP-CONCEPT.ppt
GLP-CONCEPT.pptGLP-CONCEPT.ppt
GLP-CONCEPT.ppt
 
18_Clinical Laboratory Visit - I.pdf
18_Clinical Laboratory Visit - I.pdf18_Clinical Laboratory Visit - I.pdf
18_Clinical Laboratory Visit - I.pdf
 
21_Biochemical metabolism.pdf
21_Biochemical metabolism.pdf21_Biochemical metabolism.pdf
21_Biochemical metabolism.pdf
 
2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden2013-11-26 DTL FIH symposium, Leiden
2013-11-26 DTL FIH symposium, Leiden
 
Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...Development and Regulatory Approval of Biologics in European Union (Investiga...
Development and Regulatory Approval of Biologics in European Union (Investiga...
 

More from SyedMuhammadZakria

drugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdfdrugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdf
SyedMuhammadZakria
 
mycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdfmycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdf
SyedMuhammadZakria
 
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdfemanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
SyedMuhammadZakria
 
hypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdfhypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdf
SyedMuhammadZakria
 
Hemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptxHemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptx
SyedMuhammadZakria
 
ایفائے عہد2 (1).pptx
ایفائے عہد2 (1).pptxایفائے عہد2 (1).pptx
ایفائے عہد2 (1).pptx
SyedMuhammadZakria
 
elisa-220428090127.pdf
elisa-220428090127.pdfelisa-220428090127.pdf
elisa-220428090127.pdf
SyedMuhammadZakria
 
blunt trauma wounds-2.pptx
blunt trauma wounds-2.pptxblunt trauma wounds-2.pptx
blunt trauma wounds-2.pptx
SyedMuhammadZakria
 
coagulation-181225200840.pdf
coagulation-181225200840.pdfcoagulation-181225200840.pdf
coagulation-181225200840.pdf
SyedMuhammadZakria
 
Lecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.pptLecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.ppt
SyedMuhammadZakria
 
rickettsiabypunit-copy-170914153220.pdf
rickettsiabypunit-copy-170914153220.pdfrickettsiabypunit-copy-170914153220.pdf
rickettsiabypunit-copy-170914153220.pdf
SyedMuhammadZakria
 
lecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdflecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdf
SyedMuhammadZakria
 
ranjithakm-180315143057.pdf
ranjithakm-180315143057.pdfranjithakm-180315143057.pdf
ranjithakm-180315143057.pdf
SyedMuhammadZakria
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdf
SyedMuhammadZakria
 
Cell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdfCell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdf
SyedMuhammadZakria
 
Blood Groups.pptx
Blood Groups.pptxBlood Groups.pptx
Blood Groups.pptx
SyedMuhammadZakria
 

More from SyedMuhammadZakria (16)

drugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdfdrugresistanceactivity-201223143521.pdf
drugresistanceactivity-201223143521.pdf
 
mycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdfmycobacteria-150411210246-conversion-gate01.pdf
mycobacteria-150411210246-conversion-gate01.pdf
 
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdfemanemufassalbybasheer-221122003724-5b47b246 (2).pdf
emanemufassalbybasheer-221122003724-5b47b246 (2).pdf
 
hypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdfhypersensitivity-200313073251.pdf
hypersensitivity-200313073251.pdf
 
Hemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptxHemolytic disease of newborn. GHS.pptx
Hemolytic disease of newborn. GHS.pptx
 
ایفائے عہد2 (1).pptx
ایفائے عہد2 (1).pptxایفائے عہد2 (1).pptx
ایفائے عہد2 (1).pptx
 
elisa-220428090127.pdf
elisa-220428090127.pdfelisa-220428090127.pdf
elisa-220428090127.pdf
 
blunt trauma wounds-2.pptx
blunt trauma wounds-2.pptxblunt trauma wounds-2.pptx
blunt trauma wounds-2.pptx
 
coagulation-181225200840.pdf
coagulation-181225200840.pdfcoagulation-181225200840.pdf
coagulation-181225200840.pdf
 
Lecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.pptLecture 4-Medical Mycology-.ppt
Lecture 4-Medical Mycology-.ppt
 
rickettsiabypunit-copy-170914153220.pdf
rickettsiabypunit-copy-170914153220.pdfrickettsiabypunit-copy-170914153220.pdf
rickettsiabypunit-copy-170914153220.pdf
 
lecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdflecture29-chlamydia-131112214406-phpapp01.pdf
lecture29-chlamydia-131112214406-phpapp01.pdf
 
ranjithakm-180315143057.pdf
ranjithakm-180315143057.pdfranjithakm-180315143057.pdf
ranjithakm-180315143057.pdf
 
immunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdfimmunodeficiency1-181026134939.pdf
immunodeficiency1-181026134939.pdf
 
Cell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdfCell Membrane & it-s Functions.pdf
Cell Membrane & it-s Functions.pdf
 
Blood Groups.pptx
Blood Groups.pptxBlood Groups.pptx
Blood Groups.pptx
 

Recently uploaded

Delivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and TrainingDelivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and Training
AG2 Design
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
National Information Standards Organization (NISO)
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
tarandeep35
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
TechSoup
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
Levi Shapiro
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
Krisztián Száraz
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
Celine George
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Dr. Vinod Kumar Kanvaria
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
heathfieldcps1
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
camakaiclarkmusic
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
goswamiyash170123
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
taiba qazi
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
Scholarhat
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
Bisnar Chase Personal Injury Attorneys
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
David Douglas School District
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Mohd Adib Abd Muin, Senior Lecturer at Universiti Utara Malaysia
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
SACHIN R KONDAGURI
 
kitab khulasah nurul yaqin jilid 1 - 2.pptx
kitab khulasah nurul yaqin jilid 1 - 2.pptxkitab khulasah nurul yaqin jilid 1 - 2.pptx
kitab khulasah nurul yaqin jilid 1 - 2.pptx
datarid22
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
Celine George
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
Academy of Science of South Africa
 

Recently uploaded (20)

Delivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and TrainingDelivering Micro-Credentials in Technical and Vocational Education and Training
Delivering Micro-Credentials in Technical and Vocational Education and Training
 
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
Pollock and Snow "DEIA in the Scholarly Landscape, Session One: Setting Expec...
 
S1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptxS1-Introduction-Biopesticides in ICM.pptx
S1-Introduction-Biopesticides in ICM.pptx
 
Introduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp NetworkIntroduction to AI for Nonprofits with Tapp Network
Introduction to AI for Nonprofits with Tapp Network
 
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
June 3, 2024 Anti-Semitism Letter Sent to MIT President Kornbluth and MIT Cor...
 
Advantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO PerspectiveAdvantages and Disadvantages of CMS from an SEO Perspective
Advantages and Disadvantages of CMS from an SEO Perspective
 
How to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold MethodHow to Build a Module in Odoo 17 Using the Scaffold Method
How to Build a Module in Odoo 17 Using the Scaffold Method
 
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
Exploiting Artificial Intelligence for Empowering Researchers and Faculty, In...
 
The basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptxThe basics of sentences session 5pptx.pptx
The basics of sentences session 5pptx.pptx
 
CACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdfCACJapan - GROUP Presentation 1- Wk 4.pdf
CACJapan - GROUP Presentation 1- Wk 4.pdf
 
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdfMASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
MASS MEDIA STUDIES-835-CLASS XI Resource Material.pdf
 
DRUGS AND ITS classification slide share
DRUGS AND ITS classification slide shareDRUGS AND ITS classification slide share
DRUGS AND ITS classification slide share
 
Azure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHatAzure Interview Questions and Answers PDF By ScholarHat
Azure Interview Questions and Answers PDF By ScholarHat
 
Top five deadliest dog breeds in America
Top five deadliest dog breeds in AmericaTop five deadliest dog breeds in America
Top five deadliest dog breeds in America
 
Pride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School DistrictPride Month Slides 2024 David Douglas School District
Pride Month Slides 2024 David Douglas School District
 
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptxChapter 4 - Islamic Financial Institutions in Malaysia.pptx
Chapter 4 - Islamic Financial Institutions in Malaysia.pptx
 
"Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe..."Protectable subject matters, Protection in biotechnology, Protection of othe...
"Protectable subject matters, Protection in biotechnology, Protection of othe...
 
kitab khulasah nurul yaqin jilid 1 - 2.pptx
kitab khulasah nurul yaqin jilid 1 - 2.pptxkitab khulasah nurul yaqin jilid 1 - 2.pptx
kitab khulasah nurul yaqin jilid 1 - 2.pptx
 
How to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP ModuleHow to Add Chatter in the odoo 17 ERP Module
How to Add Chatter in the odoo 17 ERP Module
 
South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)South African Journal of Science: Writing with integrity workshop (2024)
South African Journal of Science: Writing with integrity workshop (2024)
 

introductiontoclinicalchemistry-150421021353-conversion-gate01.pdf

  • 1. CLINICAL CHEMISTRY 1 LECTURE 1: Introduction to Clinical chemistry and the clinical chemistry laboratory P.B.B. Moyo, Msc(BMS) Department of Biomedical Science Malamulo College of Health Sciences Makwasa, March 23rd , 2015 3BMSCC1lec1IntroductionPmoyo18th March2015 1
  • 2. COURSE OVERVIEW • AIM: This course aims at providing students with knowledge, attitude and skills required to perform clinical chemistry investigations correctly, supervise technicians and provide sound advice to clinicians about the same wherever necessary. • GENERAL OBJECTIVES: By the end of this course you should be able to: 1. Describe the scope of clinical chemistry 2. Apply the principles of measurement indicated for CCL 3. Describe structure and metabolism of CHON, CHO, Lipids, Hormones, Electrolytes, Elements, and Organic bio-compounds 3BMSCC1lec1IntroductionPmoyo18th March2015 2
  • 3. Course overview continued 4. Describe specimen requirement specifications on patient preparation, specimen collection and handling appropriately 5. Perform investigations and analyses of the parameters in 3, above 6. Apply quality assurance principles and measures in the CCL 7. Provide information, education and communication (IEC) to the public regarding CCL roles 8.Provide required supervision for biomedical tecnnicians 9. Provide technical support to management and other hospital sub-systems. 3BMSCC1lec1IntroductionPmoyo18th March2015 3
  • 4. Lesson Overview • Define related terms • List the factors that led to the development of clinical chemistry • State the rationale of laboratory medicine and clinical chemistry in particular • Point out the areas of interests or benefits of clinical chemistry 3BMSCC1lec1IntroductionPmoyo18th March2015 4
  • 5. The scope of clinical chemistry • Introduction 1) what it is 2) why study it 3) How it is studied 4) Requirements: - equipment - personnel - reagents and test kits - consumable supplies 3BMSCC1lec1IntroductionPmoyo18th March2015 5
  • 7. history • Synthesis of urea by Friedrich Wohler in 1800 - exploration of life phenomenon to replace the misconception that ‘life was but a series of chemical reactions’ - Crude techniques but advances to understand the living material were made despite limitations, in the 19th century. Viz; 1) discovery of starch, fats and some blood proteins were isolated and characterised 2) Cholesterol in gall stones 3) chemical composition of urine • 1815 urine test for diabetes and CHO metabolism investigations started • 1836 The first clinical chemistry book was published 3BMSCC1lec1IntroductionPmoyo18th March2015 7
  • 8. history • Further developments in the 1900s - Ph meter-initially for citrus acidity testing but adapted to ph in assays, its effect on RR and later test blood pH to identify and monitor ABB treatment - Colorimeters-electronic measurement replaced visual comparison reacted tests with standard solutions i.e. objectivity replaced subjectivityESULTED IN INCREASED ACCURACY AND PRODUCTIVITY Provided the basis for the discovery of automated analysers in use today 3BMSCC1lec1IntroductionPmoyo18th March2015 8
  • 9. History – Advanced testing • 2. Dr. L. Skeggs discovered the Technicon Autoanalyser • 3. 1970 Radioisotopes were used in assays Scintillation counting devices Immunoassays • 4. Incorporation or linkage of computers to laboratory equipment - ability for data processing - monitoring of data produced - ensured accuracy - correlations and relationships with previous information (eg. Delta checks) 3BMSCC1lec1IntroductionPmoyo18th March2015 9
  • 10. Explosion of biochemical knowledge • 1. Deep probing into mysteries resulted from increased knowledge and use of instrumentation • More details could be revealed using a very small sample and in a very short time (test turn around time was greatly reduced) • 2. Hormone studies, enzyme activities, and electrophoresis, plus pharmacological investigations on drug levels became the order of the day • Therefore, clinical chemistry has become and indispensable necessity in modern, evidence based medicine 3BMSCC1lec1IntroductionPmoyo18th March2015 10
  • 11. Current Interests • 1. Indicators of a healthy life style – regular check ups e.g. Cholesterol, blood sugar • 2. Predictors of heart disease eg. Lipoproteins • 3. Markers of mental ilnes or cancer eg. Cortisol or Alfa Feto Protein (AFP) • 4. Disease specific protein markers eg. C-reactive protein and Ceruloplasmin • 5. Nutritional assessment- the healing process and mineral status • 6. Treatment monitoring eg. LFTs in ARV therapy • 7. General maintenance of health 3BMSCC1lec1IntroductionPmoyo18th March2015 11
  • 12. The Future of Clinical chemistry • 1. Certainty-more areas to explore: genetic studies, DNA probes consequently, may permit rapid and accurate detection of metabolic disorders and inborn errors of metabolism • 2. Forensic chemistry- use of DNA in partenity testing, identification of criminals and drug screaning for substance abuse eg. Athlets • 3. Development potential evidenced by: -Ion Selective Electrodes-pHM? Mbfconst.acc - Bedside (lab)testing -Paediatric patients versus adult values 4. Contributions through research discovery and ellaboration of new and existing functions and roles of certain molecules • Politics and economics will drive the future of clinical chemistry 3BMSCC1lec1IntroductionPmoyo18th March2015 12
  • 13. The clinical chemistry laboratory 1. Personnel 2. SOPs 3. Specimens-patient preparation, collection, transport and storage 4. Methods - choice criteria 5. Equipment – choice and proper use •Results and Records 6. Quality assurance 3BMSCC1lec1IntroductionPmoyo18th March2015 13
  • 14. Prerequisites of clinical chemistry work • The scientific notation of use of (systeme internationale )SI units • Ability to make bake basic computations applicable to the clinical chemistry laboratory • Availability and use of quality water: one that meets specific requirements • Availability and use of quality chemicals, reagents and consumable supplies • Adherence to collection, transport, handling and processing or testing of specimens • Application of safety and quality assurance measure in clinical chemistry laboratory work 3BMSCC1lec1IntroductionPmoyo18th March2015 14
  • 15. Summary 1. Clinical chemistry scope covers several branches 2. CC developed rapidly with the synthesis of urea due to its relation to life 3. Instrumentation made laboratory testing more efficient and productive with reduced turn around time 4. CC provides the bases for diagnostic, prognostic, forensic and drug monitoring 5. CC has pointed out special areas of interest in human health and indicators of impending diseases 6. Despite the important roles, CC success is dependent on government policies and the economy of a country 3BMSCC1lec1IntroductionPmoyo18th March2015 15